PCN59 Economics of Primary Prophylactic G-CSF Use in Preventing Neutropenia in Elderly Breast Cancer Patients Receiving Chemotherapy: Are Short-Term Increase in Costs Necessarily Bad?

Value in Health - United Kingdom
doi 10.1016/j.jval.2011.08.1160
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Effectiveness of G-CSF on the Incidence of Febrile Neutropenia and Antibiotic Usage in Gynecologic Cancer Patients Receiving Chemotherapy.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1997English

Incidence of Chemotherapy-Induced Neutropenia in HIV-infected and Uninfected Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

South African Medical Journal
Medicine
2017English

Short Term Increase in Risk of Breast Cancer After Full Term Pregnancy.

BMJ
1988English

Stability of Symptom Clusters in Patients With Breast Cancer Receiving Chemotherapy

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2018English

Stable Long-Term Risk of Leukaemia in Patients With Severe Congenital Neutropenia Maintained on G-CSF Therapy

British Journal of Haematology
Hematology
2010English

Cost-Utility of Granulocyte-Colony Stimulating Factors (G-CSFs) for Primary Prophylaxis (PP) of Chemotherapy Induced Febrile Neutropenia (FN) in Breast Cancer Patients in the Netherlands

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2013English

Cardiac Dysfunction in Cancer Patients Receiving Chemotherapy

Journal of Evolution of Medical and Dental Sciences
2015English

Clinical Predictive Models for Chemotherapy-Induced Febrile Neutropenia in Breast Cancer Patients: A Validation Study

PLoS ONE
Multidisciplinary
2014English

The Use of Prophylactic Granulocyte-Colony Stimulating Factor for Chemotherapy-Induced Febrile Neutropenia

European Oncology and Haematology
OncologyHematology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy